Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | APEX1 | P27695 | 1/20 | 0.40 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.39 |
| ▸ | IDO1 | P14902 | 2/20 | 0.39 |
| ▸ | DPP4 | P27487 | 5/20 | 0.39 |
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.37 |
| ▸ | MMP2 | P08253 | 1/20 | 0.35 |
| ▸ | FAP | Q12884 | 1/20 | 0.35 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.35 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.35 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.34 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.33 |
| ▸ | APP | P05067 | 1/20 | 0.33 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8201382 | 1.00 | CYP1A2 (0.41) | CYP1A2CYP2D6APEX1PMP22CYP3A4 | |
| SCHEMBL242930 | 0.81 | GFER (0.42) | CYP3A4DPP4DPP7DPP8DPP9 | |
| SCHEMBL242929 | 0.81 | GFER (0.42) | CYP3A4DPP4DPP7DPP8DPP9 | |
| SCHEMBL2269387 | 0.81 | GFER (0.42) | CYP3A4DPP4DPP7DPP8DPP9 | |
| SCHEMBL7431808 | 0.79 | TAAR1 (0.40) | IDO1DPP4DPP7FAPDPP8 | |
| SCHEMBL2075236 | 0.79 | CYP1A2 (0.41) | CYP1A2CYP2D6APEX1PMP22CYP3A4 | |
| SCHEMBL9503514 | 0.79 | CA2 (0.41) | SLC6A4 | |
| SCHEMBL6335 | 0.79 | TAAR1 (0.55) | CYP1A2CYP3A4SLC7A5 | |
| SCHEMBL2268272 | 0.79 | LOXL2 (0.43) | IDO1DPP4DPP7FAPDPP8 | |
| SCHEMBL1972357 | 0.79 | FFAR1 (0.41) | CYP1A2IDO1DPP4DPP7FAP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6127340-A | ESPCECIALLY THROMBIN, IN WHICH THE P1-P2 NATURAL AMIDE LINKAGE IS REPLACED BY ANOTHER BOND; INHIBITING COAGULATION OF BLOOD IN A CONTAINER; TREATMENT OR PREVENTION OF THROMBOSIS | TRIGEN LIMITED (GB) | 2000-10-03 | — | — | US | claimed |
| EP-0910583-A1 | THROMBIN INHIBITORS | TRIGEN LIMITED (GB) | 1999-04-28 | — | — | EP | claimed |
| WO-1998000443-A1 | THROMBIN INHIBITORS | TRIGEN LIMITED (GB) | 1998-01-08 | — | — | WO | claimed |
| EP-0809650-A1 | SERINE PROTEASE INHIBITORS | ELLERMAN PHARMACEUTICALS LIMITED (GB) | 1997-12-03 | — | — | EP | claimed |
| WO-1996025427-A1 | SERINE PROTEASE INHIBITORS | ELLERMAN PHARMACEUTICALS LIMITED (GB) | 1996-08-22 | — | — | WO | claimed |
| EP-0118280-B1 | ENZYME INHIBITION | Aktiebolaget Hässle (SE) | 1989-07-12 | — | — | EP | claimed |
| US-4818748-A | HYPOTENSIVE AGENTS | BAYER AKTIENGESELLSCHAFT (DE) | 1989-04-04 | — | — | US | claimed |
| US-4772686-A | ANTICOAGULANTS | AKTIEBOLAGET HASSLE (SE) | 1988-09-20 | — | — | US | claimed |
| EP-0236874-A2 | Renin inhibitors, their production and use, as well as derivatives of amino acids and amino aldehydes | BAYER AG (DE) | 1987-09-16 | — | — | EP | claimed |
| US-4638047-A | Enzyme inhibition | AKTIEBOLAGET HASSLE (SE) | 1987-01-20 | — | — | US | claimed |
| WO-1984003507-A1 | ENZYME INHIBITION | FERRING AB (SE) | 1984-09-13 | — | — | WO | claimed |
| EP-0118280-A1 | Enzyme inhibition | Aktiebolaget Hässle (SE) | 1984-09-12 | — | — | EP | claimed |
| US-6127340-A | ESPCECIALLY THROMBIN, IN WHICH THE P1-P2 NATURAL AMIDE LINKAGE IS REPLACED BY ANOTHER BOND; INHIBITING COAGULATION OF BLOOD IN A CONTAINER; TREATMENT OR PREVENTION OF THROMBOSIS | TRIGEN LIMITED (GB) | 2000-10-03 | — | — | US | disclosed |
| EP-0910583-A1 | THROMBIN INHIBITORS | TRIGEN LIMITED (GB) | 1999-04-28 | — | — | EP | disclosed |
| WO-1998000443-A1 | THROMBIN INHIBITORS | TRIGEN LIMITED (GB) | 1998-01-08 | — | — | WO | disclosed |
| WO-1996025427-A1 | SERINE PROTEASE INHIBITORS | ELLERMAN PHARMACEUTICALS LIMITED (GB) | 1996-08-22 | — | — | WO | disclosed |
| EP-0236874-A2 | Renin inhibitors, their production and use, as well as derivatives of amino acids and amino aldehydes | BAYER AG (DE) | 1987-09-16 | — | — | EP | disclosed |
| US-4638047-A | Enzyme inhibition | AKTIEBOLAGET HASSLE (SE) | 1987-01-20 | — | — | US | disclosed |
| WO-1984003507-A1 | ENZYME INHIBITION | FERRING AB (SE) | 1984-09-13 | — | — | WO | disclosed |
| EP-0118280-A1 | Enzyme inhibition | Aktiebolaget Hässle (SE) | 1984-09-12 | — | — | EP | disclosed |